NDC 12064-019 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Glaxosmithkline Manufacturing Spa.
Product ID | 12064-019_d035f7b3-3d8f-423a-8ad6-ee68464a68cb |
NDC | 12064-019 |
Product Type | Drug For Further Processing |
Proprietary Name | NDC 12064-019 |
Dosage Form | Injection, Suspension, Liposomal |
Marketing Start Date | 2015-01-01 |
Marketing Category | / DRUG FOR FURTHER PROCESSING |
Labeler Name | GlaxoSmithKline Manufacturing SpA |
NDC Exclude Flag | N |
Sample Package? | N |
Ingredient | Strength |
---|---|
DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |